Agree To Purchase Biogen Idec At $230, Earn 8.3% Using Options

Investors eyeing a purchase of Biogen Idec Inc (BIIB) stock, but tentative about paying the going market price of $320.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $230 strike, which has a bid at the time of this writing of $19.10..